Developing a vaccine to protect against Nipah virus
Preclinical development of a vaccine for Nipah virus
['FUNDING_R01'] · UNIVERSITY OF TEXAS MED BR GALVESTON · NIH-10781951
This study is working on a new vaccine to help protect healthcare workers and people at risk from the Nipah virus, which can make you very sick, by using a safe version of the virus to help your body build up its defenses.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS MED BR GALVESTON (nih funded) |
| Locations | 1 site (GALVESTON, UNITED STATES) |
| Trial ID | NIH-10781951 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a vaccine for the Nipah virus, which causes severe illness and has a high fatality rate. The approach involves using a modified virus to stimulate an immune response without causing disease. The research is conducted in a highly controlled laboratory environment due to the dangerous nature of the Nipah virus. If successful, this vaccine could be used to protect healthcare workers and individuals at risk during outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for this research include healthcare workers and individuals who may be exposed to the Nipah virus during outbreaks.
Not a fit: Patients who are not at risk of exposure to the Nipah virus or those who are already infected will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a crucial vaccine to prevent severe illness and death from Nipah virus infections.
How similar studies have performed: Other research efforts have shown promise in developing vaccines for similar high-risk pathogens, indicating potential for success in this area.
Where this research is happening
GALVESTON, UNITED STATES
- UNIVERSITY OF TEXAS MED BR GALVESTON — GALVESTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GEISBERT, THOMAS WILLIAM — UNIVERSITY OF TEXAS MED BR GALVESTON
- Study coordinator: GEISBERT, THOMAS WILLIAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.